Author: Pen Claude Lilliu Hervé
Publisher: Springer Publishing Company
ISSN: 0928-1231
Source: Pharmacy World and Science, Vol.27, Iss.2, 2005-04, pp. : 83-91
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
GPIIb-IIIa antagonists: upstream vs deferred use in acute coronary syndromes
Inpharma, Vol. 1, Iss. 1576, 2007-01 ,pp. :
GPIIb-IIIa antagonists cost effective in acute coronary syndromes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 499, 2006-01 ,pp. :
GP IIb / IIIa Blockade in Elective Percutaneous Coronary Intervention
Current Pharmaceutical Design, Vol. 10, Iss. 4, 2004-02 ,pp. :